Background: Due to developmental variations that affect medication metabolism and effects, drug safety in young populations is a major concern.
Methods: In order to assess adverse drug reactions (ADRs) and improve medication safety monitoring, this non-interventional study gathered data from 250 pediatric patients. The study was conducted over a period of 12 months from September 2021 to September 2022 at Anu Hospitals and Priya Children’s Hospital, Vijayawada.
Results: With a focus on frequently prescribed drugs in pediatric care, the study examined the frequency, intensity, and type of adverse drug reactions (ADRs).
Conclusion: With a focus on frequently prescribed drugs in pediatric care, the study examined the frequency, intensity, and type of adverse drug reactions (ADRs).
Pharmacovigilance, Paediatrics, safety monitoring, Adverse drug reactions
Aurich, B., Apele‐Freimane, D., Banaschewski, T., Chouchana, L., Day, S., Kaguelidou, F., ... & Wong, I. C. (2022). c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children–A c4c expert group white paper. British journal of clinical pharmacology, 88(12), 4997-5016.
Bethesda, M. D. (2012). Adverse drug reaction probability scale (naranjo) in drug induced liver injury. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury; National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, USA.
Eldridge, N., Wang, Y., Metersky, M., Eckenrode, S., Mathew, J., Sonnenfeld, N., ... & Krumholz, H. M. (2022). Trends in adverse event rates in hospitalized patients, 2010-2019. Jama, 328(2), 173-183.
Golder, S., Loke, Y. K., Wright, K., & Norman, G. (2016). Reporting of adverse events in published and unpublished studies of health care interventions: a systematic review. PLoS medicine, 13(9), e1002127.
Keche, Y., Gaikwad, N., & Dhaneria, S. (2021). Preventability, predictability, severity and causality assessment of adverse drug reactions reported from a teaching hospital in chhattisgarh: A retrospective analysis. Journal of Family Medicine and Primary Care, 10(7), 2541-2545.
Leitzen, S., Dubrall, D., Toni, I., Stingl, J., Christ, P., Köberle, U., ... & Sachs, B. (2023). Adverse drug reactions in children: comparison of reports collected in a pharmacovigilance project versus spontaneously collected ADR reports. Pediatric Drugs, 25(2), 203-215.
Leporini, C., De Sarro, C., Palleria, C., Caccavo, I., Piro, B., Citraro, R., & De Sarro, G. (2022). Pediatric drug safety surveillance: a 10-year analysis of adverse drug reaction reporting data in Calabria, Southern Italy. Drug Safety, 45(11), 1381-1402.
Nasso, C., Mecchio, A., Rottura, M., Valenzise, M., Menniti-Ippolito, F., Cutroneo, P. M., ... & Altavilla, D. (2020). A 7-years active pharmacovigilance study of adverse drug reactions causing children admission to a pediatric emergency department in Sicily. Frontiers in Pharmacology, 11, 1090.
Srinivasan, R., & Ramya, G. (2011). Adverse drug reaction-causality assessment. Int J Res Pharm Chem, 1(3), 606-12.
Toma, M., Felisi, M., Bonifazi, D., Bonifazi, F., Giannuzzi, V., Reggiardo, G., ... & TEDDY European Network of Excellence for Paediatric Research. (2021). Paediatric medicines in Europe: the paediatric regulation—is it time for reform?. Frontiers in medicine, 8, 593281.
